Biologics in COPD: Why, when, and who episode artwork

EPISODE · May 31, 2024 · 23 MIN

Biologics in COPD: Why, when, and who

from The APAPP Podcast · host Association of Pulmonary Advanced Practice Providers

Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA 

Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients. Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA

NOW PLAYING

Biologics in COPD: Why, when, and who

0:00 23:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The APAPP Podcast?

This episode is 23 minutes long.

When was this The APAPP Podcast episode published?

This episode was published on May 31, 2024.

What is this episode about?

Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and...

Can I download this The APAPP Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!